These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 16638596)

  • 1. Is there evidence for the evidence-based guidelines for cardiovascular disease prevention in women?
    Roberts BH; Thompson PD
    Gend Med; 2006 Mar; 3(1):5-12. PubMed ID: 16638596
    [No Abstract]   [Full Text] [Related]  

  • 2. Lipid disorders.
    Kole LA
    JAAPA; 2009 Nov; 22(11):54-5. PubMed ID: 19999177
    [No Abstract]   [Full Text] [Related]  

  • 3. Cardiovascular primary prevention: how high should we set the bar?
    Prasad V; Vandross A
    Arch Intern Med; 2012 Apr; 172(8):656-9; discussion 659. PubMed ID: 22529231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic acid, alone and in combinations, for reduction of cardiovascular risk.
    Brown BG; Zhao XQ
    Am J Cardiol; 2008 Apr; 101(8A):58B-62B. PubMed ID: 18375243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Raising HDL cholesterol: which is the best strategy?].
    Alfonso JE; Ariza ID
    Rev Assoc Med Bras (1992); 2008; 54(4):369-76. PubMed ID: 18719798
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drugs for lipids.
    Treat Guidel Med Lett; 2008 Feb; 6(66):9-16. PubMed ID: 18216759
    [No Abstract]   [Full Text] [Related]  

  • 7. Fibrates, dyslipoproteinaemia and cardiovascular disease.
    Watts GF; Dimmitt SB
    Curr Opin Lipidol; 1999 Dec; 10(6):561-74. PubMed ID: 10680050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of high-risk older persons with lipid-lowering drug therapy.
    Aronow WS
    Am J Ther; 2008; 15(2):102-7. PubMed ID: 18356628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of atorvastatin in achieving National Cholesterol Education Program low-density lipoprotein targets in women with severe dyslipidemia and cardiovascular disease or risk factors for cardiovascular disease: The Women's Atorvastatin Trial on Cholesterol (WATCH).
    McPherson R; Angus C; Murray P; Genest J;
    Am Heart J; 2001 Jun; 141(6):949-56. PubMed ID: 11376309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategies for reducing cardiovascular risk in patients with hypertriglyceridemia.
    Gorkin JU; Watson K; Knopp RH
    J Fam Pract; 2007 Aug; 56(8 Suppl Strategies):S1-7; quiz S8. PubMed ID: 18667138
    [No Abstract]   [Full Text] [Related]  

  • 11. Implications of LDL subclass B in patients at cardiovascular risk.
    Moredich C; Kark D; Keresztes P
    Nurse Pract; 2005 Jul; 30(7):16-8, 23, 26, passim; quiz 29-31. PubMed ID: 16021026
    [No Abstract]   [Full Text] [Related]  

  • 12. Is there evidence-based hypolipidemic treatment with clinical benefit beyond statins?
    Goumas GS
    Angiology; 2009; 60(1):93-8. PubMed ID: 19019838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niacin therapy lives for another day-maybe?
    Lavie CJ; Dinicolantonio JJ; Milani RV; O'Keefe JH
    J Am Coll Cardiol; 2013 May; 61(21):2197-8. PubMed ID: 23541967
    [No Abstract]   [Full Text] [Related]  

  • 14. Statins, fibrates, nicotinic acid, cholesterol absorption inhibitors, anion-exchange resins, omega-3 fatty acids: which drugs for which patients?
    Drexel H
    Fundam Clin Pharmacol; 2009 Dec; 23(6):687-92. PubMed ID: 19682084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Target levels for LDL cholesterol are put out of the running. Cholesterol should be lowered maximally in high cardiovascular risk].
    Olsson AG
    Lakartidningen; 2011 Jun 1-14; 108(22-23):1240-3. PubMed ID: 21786498
    [No Abstract]   [Full Text] [Related]  

  • 16. [The discussion on target goals in lipid reduction is still going on. The Expert Committee--a block for current cardiovascular prevention].
    Olsson AG
    Lakartidningen; 2011 Nov 23-29; 108(47):2442-3. PubMed ID: 22468387
    [No Abstract]   [Full Text] [Related]  

  • 17. Hypertriglyceridemia-why, when and how should it be treated?
    Gouni-Berthold I; Krone W
    Z Kardiol; 2005 Nov; 94(11):731-9. PubMed ID: 16258774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trial clouds use of niacin with a statin.
    Harv Heart Lett; 2011 Aug; 21(12):2. PubMed ID: 21991606
    [No Abstract]   [Full Text] [Related]  

  • 19. MY APPROACH to elevated cholesterol in women.
    Gulati M; Sharma K
    Trends Cardiovasc Med; 2016 May; 26(4):389-90. PubMed ID: 26975627
    [No Abstract]   [Full Text] [Related]  

  • 20. A Reappraisal of the Lipid Hypothesis.
    DuBroff R
    Am J Med; 2018 Sep; 131(9):993-997. PubMed ID: 29752904
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.